Ying Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Ying Fu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Chun‐Lai Jiang
National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China
1 shared publication- Huiyan Wang
Jilin Medical University, Jilin Collaborative Innovation Center for Antibody Engineering, Jilin 132013, China,(H.W.), China
1 shared publication Jia‐Qi Zhang
Jilin Medical University, Jilin, China
1 shared publicationQinying Ma
Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, China
1 shared publicationYaqi Sun
Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, China
1 shared publicationYayun Tian
Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, China
1 shared publication
Latest Publications
- Open Access
- 26 November 2021
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12
Case Report: Insulinoma Presenting as Excessive Daytime Somnolence
Currently, undiagnosed insulinomas remain a difficult clinical dilemma because its symptoms in most cases can easily be misdiagnosed as other diseases. In this article, we present the case of a 14-year-old girl who presented to our hospital with recurrent episodes of excessive daytime sleepiness and abnormal behavior during sleep that had been going on for 3 months. Insulinoma is a rare neuroendocrine tumor that causes excessive release of insulin, resulting in episodes of hypoglycemia. It usually manifests as autonomic sympathetic symptoms. These symptoms resolved rapidly with the administration of glucose. After successful removal of the tumor, daytime sleepiness and abnormal nighttime behavior of the patient did not reappear.
- 26 November 2021
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12
Open AccessCase Report: Insulinoma Presenting as Excessive Daytime Somnolence
Currently, undiagnosed insulinomas remain a difficult clinical dilemma because its symptoms in most cases can easily be misdiagnosed as other diseases. In this article, we present the case of a 14-year-old girl who presented to our hospital with recurrent episodes of excessive daytime sleepiness and abnormal behavior during sleep that had been going on for 3 months. Insulinoma is a rare neuroendocrine tumor that causes excessive release of insulin, resulting in episodes of hypoglycemia. It usually manifests as autonomic sympathetic symptoms. These symptoms resolved rapidly with the administration of glucose. After successful removal of the tumor, daytime sleepiness and abnormal nighttime behavior of the patient did not reappear.
- 28 June 2018
- Published by Wiley in The Journal of Dermatology
- Vol. 45 (8) , 986-988
Identification of a missense mutation causing exon skipping in a neurofibromatosis type 1 patient
Neurofibromatosis type 1 (NF1), caused by germ line mutations of the NF1 tumor‐suppressor gene, is one of the most common autosomal dominant disorders. Here, we reported a NF1 patient with the mutation NF1 c.4367+1G>C. This sequence change locates at the first nucleotide of NF1 intron 32 within the consensus splice site. Compared with NF1 c.4367G>C predicted to potentially damage the wild‐type donor site at c.4367, the NF1 c.4367+1G>C potentially abolishes this wild‐type donor site by in silico analysis. In vitro minigene assay revealed that the NF1 c.4367+1G>C may cause exon 32 skipping. Our result provides further evidence for its clinical significance of NF1 c.4367+1G>C in clinical practise.
- 28 June 2018
- Published by Wiley in The Journal of Dermatology
- Vol. 45 (8) , 986-988
Identification of a missense mutation causing exon skipping in a neurofibromatosis type 1 patient
Neurofibromatosis type 1 (NF1), caused by germ line mutations of the NF1 tumor‐suppressor gene, is one of the most common autosomal dominant disorders. Here, we reported a NF1 patient with the mutation NF1 c.4367+1G>C. This sequence change locates at the first nucleotide of NF1 intron 32 within the consensus splice site. Compared with NF1 c.4367G>C predicted to potentially damage the wild‐type donor site at c.4367, the NF1 c.4367+1G>C potentially abolishes this wild‐type donor site by in silico analysis. In vitro minigene assay revealed that the NF1 c.4367+1G>C may cause exon 32 skipping. Our result provides further evidence for its clinical significance of NF1 c.4367+1G>C in clinical practise.